Otitis Media and Relapsing Polychondritis
Otitis Media and Relapsing Polychondritis is a research topic within Rheumatology. Science Explorer counts 10k research works in it since 1950. 11.8% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the research related to Relapsing Polychondritis, a rare autoimmune disease characterized by recurrent inflammation of cartilage and other tissues. It also encompasses studies on VEXAS syndrome, a recently identified autoinflammatory condition associated with somatic mutations in UBA1. The papers cover various aspects including clinical features, disease activity, therapeutic options, and the role of somatic mutations in these conditions.
- Relapsing Polychondritis
- VEXAS Syndrome
- Autoinflammatory Disease
- UBA1 Mutations
- Cartilage Autoimmunity
- Clinical Features
- Therapeutic Options
- Somatic Mutations
- Disease Activity
- Biological Drug Use
- Research works
- 10k fractional, since 1950
- In the world top 10%
- 1.2k per year above
- Top-10% rate
- 11.8% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +37% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Otitis Media and Relapsing Polychondritis research?
By volume, the United States and China publish the most (367 and 189 works in 2022–2025).
By volume, 2022–2025
- 1 United States 367 works
- 2 China 189 works
- 3 France 147 works
- 4 Japan 131 works
- 5 United Kingdom 128 works
- 6 India 108 works
- 7 Germany 107 works
- 8 Spain 96 works
- 9 Italy 93 works
- 10 Türkiye 83 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Otitis Media and Relapsing Polychondritis research?
By volume in 2022–2025, Istanbul University-Cerrahpaşa publishes the most Otitis Media and Relapsing Polychondritis research, followed by Mayo Clinic in Arizona and Chinese Academy of Medical Sciences & Peking Union Medical College.
By volume, 2022–2025
- 1 Istanbul University-Cerrahpaşa Türkiye 11 works
- 2 Mayo Clinic in Arizona United States 9 works
- 3 Chinese Academy of Medical Sciences & Peking Union Medical College China 8 works
- 4 Inserm France 8 works
- 5 Sorbonne Université France 8 works
- 6 Assistance Publique – Hôpitaux de Paris France 8 works
- 7 University Medical Center Groningen Netherlands 8 works
- 8 Mayo Clinic United States 8 works
- 9 Peking Union Medical College Hospital China 7 works
- 10 Charité - Universitätsmedizin Berlin Germany 7 works
Where is Otitis Media and Relapsing Polychondritis research done?
The largest centres of Otitis Media and Relapsing Polychondritis research in 2022–2025 are Paris (France), Beijing (China), Istanbul (Türkiye) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Barcelona.
Largest cities, 2022–2025
Where it is the local speciality
- BarcelonaES · 21.8 works3.8×
Location quotient: how much more of its research is in Otitis Media and Relapsing Polychondritis than the world average.
Where is the best place to study Otitis Media and Relapsing Polychondritis?
Among universities, judged by research, Istanbul University-Cerrahpaşa and Chinese Academy of Medical Sciences & Peking Union Medical College score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Istanbul University-Cerrahpaşa Türkiye | 61.4 | 14.0% | 22.7× | 11 | +322.5% |
| 2 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 6.9 | 13.2% | 4.2× | 8 | +82.3% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Otitis Media and Relapsing Polychondritis research growing?
Output in 2018–2022 was 37% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Otitis Media and Relapsing Polychondritis.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.